IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 442 10.54660/IJMBHR.2024.5.3.88-92 Medicinal Plant Biochemistry Research to Prevent Cancer in Indonesia SulistiyowatiAtik WahyonoPoncojari RahardjantoAbdulkadir Master of Biology Education, Postgraduate Program, Universitas Muhammadiyah Malang, Indonesia 17092024 5 3 88 92 24072024 22082024 CC BY-NC-SA 4.0

Cancer prevention in Indonesia increasingly requires integrated strategies that combine risk reduction, early detection, and evidence‑based preventive interventions. Indonesia’s biodiversity and long-established herbal medicine traditions (including jamu) provide a unique opportunity for medicinal plant biochemistry research to contribute to prevention through mechanism‑aligned pathways. However, many plant-based studies remain trapped at early evidence stages—single antioxidant assays, crude extracts, uncertain compound identification, limited standardization, and scarce human biomarker studies—making translation difficult and sometimes leading to overclaims. This article provides a framework synthesis (≤2024) of medicinal plant biochemistry research relevant to cancer prevention in Indonesia. We integrate (1) biochemical mechanisms of carcinogenesis and prevention (e.g., oxidative stress and DNA damage, inflammation, detoxification balance, apoptosis, angiogenesis, immune surveillance), (2) metabolomics standards and dereplication workflows for natural products (Fiehn, 2002; Sumner et al., 2007; Wolfender et al., 2019; Qin et al., 2022), (3) evidence on natural products as sources of therapeutics and multi‑target bioactives (Newman & Cragg, 2020; Atanasov et al., 2021), and (4) governance and quality control requirements (CBD, 2011; Oberthür & Rosendal, 2014; WHO, 2011) alongside Indonesian regulatory framing for traditional medicines (BPOM, 2019). Results are presented as two conceptual figures and three implementation tables mapping key biochemical targets and assay panels, an evidence‑to‑translation ladder for prevention claims, and institutional strategies to strengthen governance readiness, reproducibility, quality assurance, and partnership-based biomarker studies. We argue that the highest-impact approach is to treat governance, taxonomy, metadata, QA/QC, and staged human evidence as core research outputs—supported by shared analytical infrastructure and clinical/public health partnerships. The paper concludes with a practical roadmap for Indonesian universities to produce credible, ethical, and scalable medicinal plant biochemistry research that supports cancer prevention.

 Indonesiacancer preventionmedicinal plantsplant biochemistrynatural productsmetabolomicsdereplicationchemopreventioninflammationoxidative stressapoptosisangiogenesisimmune modulationstandardizationBPOMWHO References Atanasov AG, Zotchev SB, Dirsch VM, International Natural Product Sciences Taskforce. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200-216. BPOM. Peraturan Badan Pengawas Obat dan Makanan Republik Indonesia No. 32 Tahun 2019 tentang Persyaratan Keamanan dan Mutu Obat Tradisional. Jakarta: Badan POM Republik Indonesia; 2019. Convention on Biological Diversity. Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization. Montreal: Secretariat of the Convention on Biological Diversity; 2011. Fiehn O. Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1-2):155-171. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674. Heinrich M, Jalil B, Potocnik T, et al. Best practice in ethnopharmacology and ethnobotany: a review and recommendations. J Ethnopharmacol. 2020;249:112376. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770-803. Oberthür S, Rosendal GK, editors. Global governance of genetic resources: access and benefit sharing after the Nagoya Protocol. Abingdon: Routledge; 2014. Qin GF, Zhang X, Zhu F, et al. MS/MS-based molecular networking: an efficient approach for natural products dereplication. Molecules. 2022;28(1):157. doi:10.3390/molecules28010157 Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 1976;36(7 Pt 2):2699-2702. Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis. Metabolomics. 2007;3(3):211-221. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3(10):768-780. Thomson CA, McCullough ML, Wertheim BC. Nutrition and cancer prevention. In: Nutrition in the Prevention and Treatment of Disease. 3rd ed. Academic Press; 2014. (Note: This appears to be a book chapter or review; full bibliographic details may vary depending on the exact source.) World Health Organization. Quality control methods for herbal materials. Geneva: World Health Organization; 2011. Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016;15(7):473-484. Wolfender JL, Litaudon M, Touboul D, Queiroz EF. Innovative strategies for natural product dereplication and identification in the metabolomics era. Nat Prod Rep. 2019;36(6):855-868. Copyright and License © The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.